​

Sage Therapeutics (SAGE) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Sage Therapeutics Revenue Highlights

Latest Revenue (Y)

$41.24M

Latest Revenue (Q)

$14.06M

Main Segment (Y)

Collaboration Revenue Related Party

Sage Therapeutics Revenue by Period

Sage Therapeutics Revenue by Year

DateRevenueChange
2024-12-31$41.24M-52.30%
2023-12-31$86.45M1024.84%
2022-12-31$7.69M21.85%
2021-12-31$6.31M-99.43%
2020-12-31$1.11B16123.06%
2019-12-31$6.87M-92.39%
2018-12-31$90.27M100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31-100.00%
2012-12-31--

Sage Therapeutics generated $41.24M in revenue during NA 2024, up -52.30% compared to the previous quarter, and up 600.51% compared to the same period a year ago.

Sage Therapeutics Revenue by Quarter

DateRevenueChange
2025-03-31$14.06M9.73%
2024-12-31$12.82M7.96%
2024-09-30$11.87M37.17%
2024-06-30$8.65M9.52%
2024-03-31$7.90M-89.87%
2023-12-31$77.97M2770.84%
2023-09-30$2.72M9.78%
2023-06-30$2.47M-24.89%
2023-03-31$3.29M14.97%
2022-12-31$2.87M64.75%
2022-09-30$1.74M15.86%
2022-06-30$1.50M-5.12%
2022-03-31$1.58M-3.65%
2021-12-31$1.64M14.03%
2021-09-30$1.44M-12.36%
2021-06-30$1.64M3.79%
2021-03-31$1.58M-99.86%
2020-12-31$1.11B67574.56%
2020-09-30$1.64M50.51%
2020-06-30$1.09M-52.36%
2020-03-31$2.29M16.63%
2019-12-31$1.96M-45.10%
2019-09-30$3.57M308.93%
2019-06-30$873.00K87.74%
2019-03-31$465.00K70.33%
2018-12-31$273.00K100.00%
2018-09-30--100.00%
2018-06-30$90.00M100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31--

Sage Therapeutics generated $14.06M in revenue during Q1 2025, up 9.73% compared to the previous quarter, and up 18.04% compared to the same period a year ago.

Sage Therapeutics Revenue Breakdown

Sage Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24Dec 23Dec 22Dec 21Dec 20
Collaboration Revenue Related Party$36.09M$824.00K---
Other Collaboration Revenue$1.58M$177.00K---
Product$3.57M$10.45M$7.69M$6.31M$6.70M
Collaboration Revenue----$1.11B

Sage Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 24: Collaboration Revenue Related Party (87.50%), Product (8.67%), and Other Collaboration Revenue (3.84%).

Quarterly Revenue by Product

Product/ServiceMar 25Dec 24Sep 24Jun 24Dec 23Sep 23Jun 23Mar 23Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19
Other Revenue$236.00K---------------
Collaboration Revenue Related Party$13.83M$17.64M$11.03M$7.42M------------
Other Collaboration Revenue-$314.00K$634.00K$634.00K------------
Product-$2.13M$843.00K$600.00K$1.98M$2.72M$2.46M$3.29M$1.58M$1.69M$1.64M$1.09M$2.29M$1.96M$1.48M$519.00K
Collaboration Revenue-----$14.00K-$2.09M$354.00K-------

Sage Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Mar 25: Collaboration Revenue Related Party (98.32%), and Other Revenue (1.68%).

Sage Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
INCYIncyte$4.24B$1.05B
ALNYAlnylam Pharmaceuticals$2.25B$594.19M
APLSApellis Pharmaceuticals$709.95M$212.53M
BPMCBlueprint Medicines$508.82M$149.41M
IMCRImmunocore$310.20M$84.05M
KRYSKrystal Biotech$290.51M$91.14M
ARVNArvinas$263.40M$188.80M
MDGLMadrigal Pharmaceuticals$180.13M$137.25M
DAWNDay One Biopharmaceuticals$131.16M$29.21M
AMLXAmylyx Pharmaceuticals$87.37M$-665.00K
SAGESage Therapeutics$41.24M$14.06M
STOKStoke Therapeutics$36.55M$22.61M
RLAYRelay Therapeutics$10.01M$7.68M
AKROAkero Therapeutics--
BDTXBlack Diamond Therapeutics--
VTYXVentyx Biosciences--
NUVLNuvalent--
DMACDiaMedica Therapeutics--
TERNTerns Pharmaceuticals--
PLRXPliant Therapeutics--

SAGE Revenue FAQ

What is Sage Therapeutics’s yearly revenue?

Sage Therapeutics's yearly revenue for 2024 was $41.24M, representing a decrease of -52.30% compared to 2023. The company's yearly revenue for 2023 was $86.46M, representing an increase of 1024.84% compared to 2022. SAGE's yearly revenue for 2022 was $7.69M, representing an increase of 21.85% compared to 2021.

What is Sage Therapeutics’s quarterly revenue?

Sage Therapeutics's quarterly revenue for Q1 2025 was $14.06M, a 9.73% increase from the previous quarter (Q4 2024), and a 77.97% increase year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $12.82M, a 7.96% increase from the previous quarter (Q3 2024), and a -83.56% decrease year-over-year (Q4 2023). SAGE's quarterly revenue for Q3 2024 was $11.87M, a 37.17% increase from the previous quarter (Q2 2024), and a 337.08% increase year-over-year (Q3 2023).

What is Sage Therapeutics’s revenue growth rate?

Sage Therapeutics's revenue growth rate for the last 3 years (2022-2024) was 436.60%, and for the last 5 years (2020-2024) was -96.30%.

What are Sage Therapeutics’s revenue streams?

Sage Therapeutics's revenue streams in c 24 are Collaboration Revenue Related Party, Other Collaboration Revenue, and Product. Collaboration Revenue Related Party generated $36.09M in revenue, accounting 87.50% of the company's total revenue, up 4279.49% year-over-year. Other Collaboration Revenue generated $1.58M in revenue, accounting 3.84% of the company's total revenue, up 793.79% year-over-year. Product generated $3.57M in revenue, accounting 8.67% of the company's total revenue, down -65.81% year-over-year.

What is Sage Therapeutics’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Sage Therapeutics was Collaboration Revenue Related Party. This segment made a revenue of $36.09M, representing 87.50% of the company's total revenue.